Br[CH2:2][C:3]([O:5]CC)=[O:4].[Cl:8][C:9]1[CH:14]=[CH:13][C:12]([CH:15]([NH:34][CH:35]=[N:36][C:37]#[N:38])[C:16]2[CH:17]=[C:18]3[C:23](=[CH:24][CH:25]=2)[N:22]([CH3:26])[C:21](=[O:27])[CH:20]=[C:19]3[C:28]2[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=2)=[CH:11][CH:10]=1.[K].[CH3:40][C:41](O)(C)C.O>CS(C)=O.C(OCC)(=O)C>[CH2:40]([CH:2]([C:3]([OH:5])=[O:4])[N:34]([CH:15]([C:12]1[CH:11]=[CH:10][C:9]([Cl:8])=[CH:14][CH:13]=1)[C:16]1[CH:17]=[C:18]2[C:23](=[CH:24][CH:25]=1)[N:22]([CH3:26])[C:21](=[O:27])[CH2:20][CH:19]2[C:28]1[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=1)[CH:35]=[N:36][C:37]#[N:38])[CH3:41]Ethyl 2-bromoacetate (2.45 ml) was added dropwise at 5° C. to a solution of intermediate (5-c) (9 g) and 2-methyl-2-propanol potassium salt (2.37 g) in dimethyl sulfoxide (100 ml) and the mixture was stirred at room temperature overnight. Water and ethyl acetate were added, the organic layer was decanted, dried (MgSO4), filtered off and evaporated till dryness. The product was used without further purification, yielding (±)-ethyl N-[(4-chlorophenyl)(2,3-dihydro-1-methyl-2-oxo-4-phenyl-6-quinolinyl)-methyl]-N-[(cyanoimino)methyl]glycine (interm. 5-d).